NPI registry status
Active
2026 NPPES data Pharmacotherapy Pharmacist NPI 1033441332 PHD
Verify on CMS → Mayram Abramov, PHD
Pharmacotherapy Pharmacist in New York, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,070 in Pharmacotherapy Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
123
Medicare Part D claims · 106 beneficiaries · Pharmacotherapy Pharmacist avg: 433
Generic prescribing
0%
generic claims · 100% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mayram Abramov, PHD filed 123 Medicare Part D claims in 2024 as a Pharmacotherapy Pharmacist in New York, New York, prescribing 0% generic.
- 123
- Part D claims, 2024
- 0%
- generic prescribing
- ≥34th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mayram Abramov, PHD
Bare NPI registry listing — limited federal enrichment beyond basic enumeration. Verify all credentials with official sources.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1033441332), first enumerated 02/11/2010.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 123 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Mayram Abramov, PHD's individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1033441332 · Pharmacotherapy Pharmacist
NPI-10 · ENUM-MID · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1033441332
- ENUM-MID 2010
- TAX-MID 6K Pharmacotherapy Pharmacist
- RX-LIGHT 123
- BOOK-THIN 239 in New York
- PHOTO-ENUM Thao Nguyen · 2010
Mayram Abramov, PHD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
123 ≥ 34th percentile 34% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
What does the federal data show about Mayram Abramov, PHD?
Quality data not reportedPrimary specialty
Pharmacotherapy Pharmacist
Medicare Part D claims
123 72% vs specialty avg
Specialty distribution in New York
How Pharmacotherapy Pharmacist compares to other specialties among New York providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pharmacotherapy Pharmacist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1033441332 |
|---|---|
| Specialty | Pharmacotherapy Pharmacist |
| Credentials | PHD |
| Gender | Female |
| NPI Issued | 02/11/2010 |
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Mayram Abramov, PHD. To verify Mayram Abramov, PHD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Mayram Abramov, PHD - brand share 100.0%
Pharmacotherapy Pharmacist average
100% brand-name claims vs 0% generic, on 123 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
123
Total Claims
$23K
Total Drug Cost
106
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 123
- Total Day Supply
- 123
- Brand vs Generic
- 100% brand / 0% generic
- Brand Drug Cost
- $23K
- Generic Drug Cost
- $0
Patient Demographics
- Average Patient Age
- 74.0 years
- Avg HCC Risk Score
- 1.12
- Gender Split
- 55% female / 45% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mayram Abramov, PHD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Shingrix
Shingrix
50 claims
- Arexvy
Arexvy
28 claims
- Boostrix Tdap
Boostrix Tdap
23 claims
- Abrysvo
Abrysvo
20 claims
| Drug | Claims |
|---|---|
| Shingrix Varicella-Zoster Ge/As01b/Pf | 50 |
| Arexvy Rsvpref3 Antigen/As01e/Pf | 28 |
| Boostrix Tdap Diphth,pertuss(Acell),tet Vac | 23 |
| Abrysvo Rsv Vacc, Pref A And Pref B/Pf | 20 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pharmacotherapy Pharmacist Overview
How Mayram Abramov, PHD fits within the Pharmacotherapy Pharmacist landscape nationally.
6,070
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
433
Avg Claims per Provider
Mayram Abramov, PHD's 123 claims are below the specialty average of 433.
Nationwide Pharmacotherapy Pharmacist peers with similar MIPS or enrollment year
Two federal-record peer sets for Abramov, both outside New York so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2010)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pharmacotherapy Pharmacist Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Abramov.
One of 239 Pharmacotherapy Pharmacist providers enrolled in New York, 5 are shown here.
Dr. Aya Abukwaik
PHARMD
New York, NY
Lauren Adamchick
Buffalo, NY
Dr. Nabila Ahmed-Sarwar
PHARM.D.
Rochester, NY
Dr. Eseoghene Akamune
PHARMD
New York, NY
Norberto Alberto
RPH, MS, HSCD
Massapequa, NY
Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mayram Abramov, PHD's specialty? ▼
Mayram Abramov, PHD specializes in Pharmacotherapy Pharmacist and practices in New York, New York. Credentials: PHD.
How much does Mayram Abramov, PHD prescribe under Medicare Part D? ▼
In 2024, Mayram Abramov, PHD wrote 123 Medicare Part D claims totaling $23K in drug costs for 106 beneficiaries.
Where is Mayram Abramov, PHD located? ▼
Mayram Abramov, PHD is located at 773 LEXINGTON AVE, New York, NY, 10065. Phone: (347) 622-2946.
What is Mayram Abramov, PHD's NPI number? ▼
Mayram Abramov, PHD's National Provider Identifier (NPI) is 1033441332, issued on 02/11/2010.
Does Mayram Abramov, PHD prescribe more brand-name or generic drugs? ▼
Mayram Abramov, PHD's prescribing is 100% brand-name and 0% generic drugs by claim count, with $23K in brand drug costs.
How many Pharmacotherapy Pharmacist providers are there in the US? ▼
There are 6,070 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 433 Medicare Part D claims per year.
What drugs does Mayram Abramov, PHD prescribe most often? ▼
Based on 2024 Medicare Part D data, Mayram Abramov, PHD's most frequently prescribed drugs include Shingrix, Arexvy, Boostrix Tdap. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mayram Abramov, PHD accept Medicare? ▼
Mayram Abramov, PHD appears in CMS Medicare data with 123 Part D claims and 106 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mayram Abramov, PHD's credentials? ▼
Mayram Abramov, PHD's NPI is 1033441332 with credentials PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.